Redwood City, CA, United States of America

Jo-Anne Hongo

This inventor holds 30 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Antibody Therapeutics. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jo-Anne Hongo. Retrieved from https://idiyas.com/inventor/jo-anne-hongo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 9)

% Patents Active = 40.0

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 5.6

ph-index = 8

Forward Citations = 262(Granted Patents)

Location History:

Redwood City, CA (US) (2007 - 2022)
South San Francisco, CA (US) (2015 - 2022)

Company Filing History:

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Anti-FcRH5 Antibodies

Anti-PD-L1 Antibodies

Tumor Treatment

Vascular Development

Idiotypic Antibodies

Neuropilin Antibodies

RON Agonists

NLRR-1 Antagonists

Hematopoietic Tumors

Monoclonal Antibodies

Cancer Analysis

Vascularization Modulation

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12630636 - ANTI-FCRH5 ANTIBODIES (2026-05-19),

2. 11352431 - Anti-FCRH5 antibodies (2022-06-07),

3. 11279762 - Idiotypic antibodies against anti-PD-L1 antibodies and uses thereof (2022-03-22),

4. 10435471 - Anti-FcRH5 antibodies (2019-10-08),

5. 10005848 - Method of reducing blood glucose by administering RON agonists (2018-06-26),

6. 9632091 - Compositions and methods for prostate cancer analysis (2017-04-25),

7. 9580514 - Compositions and methods for the diagnosis and treatment of tumor (2017-02-28),

8. 9360484 - Anti-FcRH5 antibodies and immunoconjugates and methods of use (2016-06-07),

9. 9175089 - Anti-LGR5 antibodies and immunoconjugates (2015-11-03),

10. 9139659 - Idiotypic antibodies and uses thereof (2015-09-22),

11. 9017951 - Anti-FcRH5 antibodies and immunoconjugates and methods of use (2015-04-28),

12. 8993249 - Anti-neuropilin antibodies and methods of use (2015-03-31),

13. 8790646 - Compositions and methods for modulating vascular development (2014-07-29),

14. 8691222 - NLRR-1 antagonists and uses thereof (2014-04-08),

15. 8617559 - Anti-FcRH5 antibodies and immunoconjugates and methods of use (2013-12-31),

Title: The Innovative Mind of Jo-Anne Hongo

Introduction: Jo-Anne Hongo, a visionary inventor based in Redwood City, CA, is known for his groundbreaking contributions to the field of technology and innovation. Despite facing challenges in a male-dominated industry, Jo-Anne has persevered and made a significant impact with his inventive spirit.

Latest Patents: Jo-Anne Hongo holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies. His most recent patents focus on enhancing data security in cloud computing and developing eco-friendly solutions for urban transportation.

Career Highlights: With a career spanning over two decades, Jo-Anne Hongo has worked for leading tech companies in Silicon Valley, where he has spearheaded research and development projects that have revolutionized the industry. His innovative ideas have led to the successful launch of products that have improved the lives of many.

Collaborations: Jo-Anne Hongo is known for his collaborative nature, often partnering with other inventors, engineers, and researchers to bring his ideas to life. His ability to work effectively in multidisciplinary teams has resulted in the creation of cutting-edge technologies that have set new standards in the industry.

Conclusion: Jo-Anne Hongo's passion for innovation, coupled with his determination to overcome obstacles, has established him as a respected figure in the world of inventors. His relentless pursuit of excellence and commitment to pushing the boundaries of what is possible continue to inspire future generations of inventors and innovators

Profile summary based on public USPTO records.